清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Safety and Feasibility Assessment of Repetitive Vascular Occlusion Stimulus (RVOS) Application to Multi-Organ Failure Critically Ill Patients: A Pilot Randomised Controlled Trial

医学 病危 重症监护医学 随机对照试验 外科
作者
Ismita Chhetri,Julie E. A. Hunt,Jeewaka R. Mendis,Lui G. Forni,Justin Kirk-Bayley,Ian White,Jonathan Cooper,Karthik Somasundaram,Nikunj Shah,Stephen David Patterson,Zudin Puthucheary,Hugh Montgomery,Ben C. Creagh-Brown
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:11 (14): 3938-3938 被引量:1
标识
DOI:10.3390/jcm11143938
摘要

Muscle wasting is implicated in the pathogenesis of intensive care unit acquired weakness (ICU-AW), affecting 40% of patients and causing long-term physical disability. A repetitive vascular occlusion stimulus (RVOS) limits muscle atrophy in healthy and orthopaedic subjects, thus, we explored its application to ICU patients. Adult multi-organ failure patients received standard care +/− twice daily RVOS {4 cycles of 5 min tourniquet inflation to 50 mmHg supra-systolic blood pressure, and 5 min complete deflation} for 10 days. Serious adverse events (SAEs), tolerability, feasibility, acceptability, and exploratory outcomes of the rectus femoris cross-sectional area (RFCSA), echogenicity, clinical outcomes, and blood biomarkers were assessed. Only 12 of the intended 32 participants were recruited. RVOS sessions (76.1%) were delivered to five participants and two could not tolerate it. No SAEs occurred; 75% of participants and 82% of clinical staff strongly agreed or agreed that RVOS is an acceptable treatment. RFCSA fell significantly and echogenicity increased in controls (n = 5) and intervention subjects (n = 4). The intervention group was associated with less frequent acute kidney injury (AKI), a greater decrease in the total sequential organ failure assessment score (SOFA) score, and increased insulin-like growth factor-1 (IGF-1), and reduced syndecan-1, interleukin-4 (IL-4) and Tumor necrosis factor receptor type II (TNF-RII) levels. RVOS application appears safe and acceptable, but protocol modifications are required to improve tolerability and recruitment. There were signals of possible clinical benefit relating to RVOS application.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
hy完成签到,获得积分10
4秒前
nano完成签到 ,获得积分10
13秒前
RZH发布了新的文献求助10
22秒前
机智的如曼完成签到,获得积分10
32秒前
Xzx1995完成签到 ,获得积分10
34秒前
FashionBoy的应助被科研通管家采纳,获得10
37秒前
fairytaler的应助被科研通管家采纳,获得10
37秒前
现代的初之完成签到,获得积分10
43秒前
大模型的应助被蜗牛好好飞采纳,获得10
44秒前
ChatGPT完成签到,获得积分10
46秒前
慕青的应助被蜗牛好好飞采纳,获得10
50秒前
夏同学完成签到 ,获得积分10
51秒前
今后的应助被蜗牛好好飞采纳,获得10
56秒前
wwrjj完成签到,获得积分0
57秒前
搜集达人的应助被cc采纳,获得10
58秒前
大模型的应助被蜗牛好好飞采纳,获得10
1分钟前
1分钟前
1分钟前
御坂10576号完成签到,获得积分10
1分钟前
1分钟前
义气的雅琴完成签到,获得积分10
1分钟前
cc发布了新的文献求助10
1分钟前
NexusExplorer的应助被蜗牛好好飞采纳,获得10
1分钟前
Harlotte完成签到 ,获得积分0
1分钟前
蒋不惜完成签到,获得积分10
1分钟前
changfox完成签到,获得积分10
1分钟前
hyk完成签到 ,获得积分10
1分钟前
milalala完成签到 ,获得积分10
1分钟前
浚稚完成签到 ,获得积分10
1分钟前
1分钟前
冷傲的夜白完成签到,获得积分10
1分钟前
岳晓燕完成签到 ,获得积分10
1分钟前
1分钟前
清脆代真发布了新的文献求助50
1分钟前
1分钟前
谭访冬完成签到,获得积分10
2分钟前
MUAN完成签到 ,获得积分10
2分钟前
2分钟前
细腻海瑶完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173230
求助须知:如何正确求助?哪些是违规求助? 9565593
关于积分的说明 21780525
捐赠科研通 7767429
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697